(Q44271915)

1 December 2017

title

The hidden alternative: getting investigational treatments off-study (English)

1 reference

1 December 2017

Jerry Menikoff

1

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

361

1 reference

1 December 2017

issue

9351

1 reference

1 December 2017

page(s)

63-67

1 reference

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

Is informed consent always necessary for randomized, controlled trials? .

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

Arizona's cancer clinical trials law: flawed process, flawed product

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912165-4

7 January 2021

10.1016/S0140-6736(03)12165-4

Identifiers

DOI

1 reference

1 December 2017

1 reference